{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:18:48Z","timestamp":1790961528750,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To investigate the association between obesity and orbital fat expansion in proptosis of thyroid eye disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This observational study retrospectively enrolled 87 participants who received orbital fat decompression surgery for thyroid eye disease. Primary outcome measures included average body mass index (BMI) and the proportion of the study sample with overweight and obesity, compared with the general Taiwanese population. Secondary outcome measures included the association of obesity with proptosis severity, removed fat volume, and thyroid status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The average BMI (25.59\u2009\u00b1\u20094.36\u00a0kg\/m<jats:sup>2<\/jats:sup>) of the study sample was significantly higher than that in the general population of Taiwan (24.5\u00a0kg\/m<jats:sup>2<\/jats:sup>; <jats:italic>P<\/jats:italic>\u2009=\u20090.012). Participants with overweight (19.52\u2009\u00b1\u20093.52\u00a0mm) and obesity (21.25\u2009\u00b1\u20093.76\u00a0mm) exhibited significantly more severe proptosis than participants without overweight (18.05\u2009\u00b1\u20093.37\u00a0mm) and without obesity (18.09\u2009\u00b1\u20093.02\u00a0mm; <jats:italic>P<\/jats:italic>\u2009=\u20090.029 and <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001, respectively). In addition, a significantly greater orbital fat volume was removed from the group with obesity (4.61\u2009\u00b1\u20091.17\u00a0ml) versus that without obesity (3.57\u2009\u00b1\u20091.12 ml; <jats:italic>P<\/jats:italic>\u2009=\u20090.021). A positive correlation between BMI and removed fat volume was noted (correlation coefficient\u2009=\u20090.291, <jats:italic>P<\/jats:italic>\u2009=\u20090.005). BMI was an independent factor predicting both proptosis severity (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and removed orbital fat volume (<jats:italic>P<\/jats:italic>\u2009=\u20090.02).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Obesity is associated with orbital fat expansion and consequently more severe proptosis in thyroid eye disease. Weight control may be a potential strategy to prevent thyroid-associated exophthalmos.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-024-03824-9","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T09:11:27Z","timestamp":1735809087000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association of obesity with orbital fat expansion in thyroid eye disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Po-Chin","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Chun","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Shan","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chieh","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"issue":"1","key":"3824_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/bjophthalmol-2016-309888","volume":"102","author":"AM Cheng","year":"2018","unstructured":"Cheng AM, Wei YH, Tighe S, Sheha H, Liao SL. Long-term outcomes of orbital fat decompression in Graves\u2019 orbitopathy. Br J Ophthalmol. 2018;102(1):69\u201373.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"3824_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/iovs.62.9.24","volume":"62","author":"DW Kim","year":"2021","unstructured":"Kim DW, Taneja K, Hoang T, Santiago CP, McCulley TJ, Merbs SL, et al. Transcriptomic profiling of control and thyroid-Associated Orbitopathy (TAO) Orbital Fat and TAO Orbital fibroblasts undergoing adipogenesis. Invest Ophthalmol Vis Sci. 2021;62(9):24.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"3824_CR3","first-page":"3249","volume":"41","author":"M Crisp","year":"2000","unstructured":"Crisp M, Starkey KJ, Lane C, Ham J, Ludgate M. Adipogenesis in thyroid eye disease. Invest Ophthalmol Vis Sci. 2000;41(11):3249\u201355.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3824_CR4","doi-asserted-by":"publisher","first-page":"7453260","DOI":"10.1155\/2019\/7453260","volume":"2019","author":"D \u0141acheta","year":"2019","unstructured":"\u0141acheta D, Mi\u015bkiewicz P, G\u0142uszko A, Nowicka G, Struga M, Kantor I, et al. Immunological aspects of Graves\u2019 Ophthalmopathy. Biomed Res Int. 2019;2019:7453260.","journal-title":"Biomed Res Int"},{"issue":"1","key":"3824_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/bjophthalmol-2015-307399","volume":"100","author":"JJ Khong","year":"2016","unstructured":"Khong JJ, McNab AA, Ebeling PR, Craig JE, Selva D. Pathogenesis of thyroid eye disease: review and update on molecular mechanisms. Br J Ophthalmol. 2016;100(1):142\u201350.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"3824_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/sj.eye.6701925","volume":"20","author":"CC Tsai","year":"2006","unstructured":"Tsai CC, Kau HC, Kao SC, Hsu WM. Exophthalmos of patients with Graves\u2019 disease in Chinese of Taiwan. Eye (Lond). 2006;20(5):569\u201373.","journal-title":"Eye (Lond)"},{"key":"3824_CR7","doi-asserted-by":"publisher","first-page":"8526","DOI":"10.1038\/srep08526","volume":"5","author":"D Wu","year":"2015","unstructured":"Wu D, Liu X, Wu D, Di X, Guan H, Shan Z, et al. Normal values of Hertel exophthalmometry in a Chinese Han population from Shenyang, Northeast China. Sci Rep. 2015;5:8526.","journal-title":"Sci Rep"},{"key":"3824_CR8","doi-asserted-by":"publisher","first-page":"611845","DOI":"10.3389\/fendo.2020.611845","volume":"11","author":"G Panagiotou","year":"2020","unstructured":"Panagiotou G, Perros P. Asymmetric Graves\u2019 Orbitopathy. Front Endocrinol (Lausanne). 2020;11:611845.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3824_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/opo.12009","volume":"33","author":"RA Armstrong","year":"2013","unstructured":"Armstrong RA. Statistical guidelines for the analysis of data obtained from one or both eyes. Ophthalmic Physiol Opt. 2013;33(1):7\u201314.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"3","key":"3824_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ajo.2011.08.032","volume":"153","author":"A Karakosta","year":"2012","unstructured":"Karakosta A, Vassilaki M, Plainis S, Elfadl NH, Tsilimbaris M, Moschandreas J. Choice of analytic approach for eye-specific outcomes: one eye or two? Am J Ophthalmol. 2012;153(3):571\u2013e91.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"3824_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.sjopt.2017.05.017","volume":"31","author":"E Al-Sharif","year":"2017","unstructured":"Al-Sharif E, Alsuhaibani AH. Fat-removal orbital decompression for thyroid associated orbitopathy: the right procedure for the right patient. Saudi J Ophthalmol. 2017;31(3):156\u201361.","journal-title":"Saudi J Ophthalmol"},{"issue":"3","key":"3824_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ajo.2010.08.042","volume":"151","author":"SL Liao","year":"2011","unstructured":"Liao SL, Huang SW. Correlation of retrobulbar volume change with resected orbital fat volume and proptosis reduction after fatty decompression for Graves ophthalmopathy. Am J Ophthalmol. 2011;151(3):465\u2013e91.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"3824_CR13","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1001\/jama.1987.03400020088037","volume":"258","author":"DS Cooper","year":"1987","unstructured":"Cooper DS, Subclinical Hypothyroidism. JAMA. 1987;258(2):246\u20137.","journal-title":"JAMA"},{"issue":"3","key":"3824_CR14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1530\/EJE-09-0566","volume":"162","author":"T Ittermann","year":"2010","unstructured":"Ittermann T, Haring R, Sauer S, Wallaschofski H, D\u00f6rr M, Nauck M, et al. Decreased serum TSH levels are not associated with mortality in the adult northeast German population. Eur J Endocrinol. 2010;162(3):579\u201385.","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"3824_CR15","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1007\/s00268-013-2201-8","volume":"37","author":"M Said","year":"2013","unstructured":"Said M, Chiu V, Haigh PI. Hypothyroidism after hemithyroidectomy. World J Surg. 2013;37(12):2839\u201344.","journal-title":"World J Surg"},{"issue":"6\u20137","key":"3824_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ejcb.2013.06.001","volume":"92","author":"AT Ali","year":"2013","unstructured":"Ali AT, Hochfeld WE, Myburgh R, Pepper MS. Adipocyte and adipogenesis. Eur J Cell Biol. 2013;92(6\u20137):229\u201336.","journal-title":"Eur J Cell Biol"},{"key":"3824_CR17","doi-asserted-by":"crossref","unstructured":"Lu C, Lai CL, Yang CM, Liao KC, Kao CS, Chang TC et al. The Relationship between Obesity-Related Factors and Graves\u2019 Orbitopathy: A Pilot Study. Med (Kaunas). 2022;58(12).","DOI":"10.3390\/medicina58121748"},{"issue":"3","key":"3824_CR18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/archopht.120.3.380","volume":"120","author":"M Kazim","year":"2002","unstructured":"Kazim M, Goldberg RA, Smith TJ. Insights into the pathogenesis of thyroid-associated orbitopathy: evolving rationale for therapy. Arch Ophthalmol. 2002;120(3):380\u20136.","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"3824_CR19","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1177\/1120672119852322","volume":"30","author":"S Ugradar","year":"2020","unstructured":"Ugradar S, Rootman DB. Orbital fat expansion in thyroid eye disease is related to age. Eur J Ophthalmol. 2020;30(5):1004\u20137.","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"3824_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1210\/jcem.87.1.8164","volume":"87","author":"TJ Smith","year":"2002","unstructured":"Smith TJ, Koumas L, Gagnon A, Bell A, Sempowski GD, Phipps RP, et al. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab. 2002;87(1):385\u201392.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3824_CR21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2214\/ajr.146.3.459","volume":"146","author":"RG Peyster","year":"1986","unstructured":"Peyster RG, Ginsberg F, Silber JH, Adler LP. Exophthalmos caused by excessive fat: CT volumetric analysis and differential diagnosis. AJR Am J Roentgenol. 1986;146(3):459\u201364.","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"3824_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00417-002-0498-3","volume":"240","author":"Y Nishida","year":"2002","unstructured":"Nishida Y, Tian S, Isberg B, Hayashi O, Tallstedt L, Lennerstrand G. Significance of orbital fatty tissue for exophthalmos in thyroid-associated ophthalmopathy. Graefes Arch Clin Exp Ophthalmol. 2002;240(7):515\u201320.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"3824_CR23","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1161\/STROKEAHA.113.000833","volume":"44","author":"FA Wollenweber","year":"2013","unstructured":"Wollenweber FA, Zietemann V, Gschwendtner A, Opherk C, Dichgans M. Subclinical hyperthyroidism is a risk factor for poor functional outcome after ischemic stroke. Stroke. 2013;44(5):1446\u20138.","journal-title":"Stroke"},{"key":"3824_CR24","first-page":"330","volume":"2","author":"S Dipankar","year":"2012","unstructured":"Dipankar S, Mali BY, Borade NG, Patwardhan MH. Estimation of lipid Profile, Body Fat percentage, body Mass Index, Waist to hip ratio in patients with hypothyroidism and hyperthyroidism. J Physiol Pharmacol Adv. 2012;2:330\u20136.","journal-title":"J Physiol Pharmacol Adv"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03824-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-024-03824-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03824-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T20:03:44Z","timestamp":1735848224000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-024-03824-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3824"],"URL":"https:\/\/doi.org\/10.1186\/s12886-024-03824-9","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by Institutional Review Board of National Cheng Kung University Hospital (B-ER-110-290), and an informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No identifying image was included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}